CryoPort (CYRX)

• Market cap: $389M
• 1 day: 2.34%
• 5 days: -4.02%
• 1 month: 18.35%
• 3 months: -1.01%
• 6 months: -0.51%
• Year to date: -49.09%
• 1 year: -51.03%
• 5 years: -52.01%
• 10 years: 249.78%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Employees: 1,170

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

979% more call options, than puts

Call options by funds: $5.09M | Put options by funds: $472K

19% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 47

1% more capital invested

Capital invested by funds: $371M [Q2] → $376M (+$5.28M) [Q3]

4% less funds holding

Funds holding: 157 [Q2] → 150 (-7) [Q3]

14.98% less ownership

Funds ownership: 109.0% [Q2] → 94.02% (-14.98%) [Q3]

24% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 29

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $9 14% upside
• Avg. target: $12 52% upside
• High target: $15 91% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Roth MKM Richard Baldry 37% 1-year accuracy 7 / 19 met price target	91% upside $15	Buy Maintained	8 Nov 2024
UBS Dan Leonard 29% 1-year accuracy 2 / 7 met price target	14% upside $9	Neutral Maintained	18 Oct 2024